Covered recipient · General Payments record
IVAN C KETTER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$589.05
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $158.77 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $66.27 | 4 |
| Amgen Inc. | $34.17 | 2 |
| Saluda Medical Americas, Inc. | $28.83 | 1 |
| Ascensia Diabetes Care US Inc. | $15.48 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.07 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104056304 | CMS |
| ABBVIE INC. | $13.29 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104056306 | CMS |
| ABBVIE INC. | $20.95 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104056308 | CMS |
| ABBVIE INC. | $16.96 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104056310 | CMS |
| Amgen Inc. | $17.97 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117295642 | CMS |
| Amgen Inc. | $16.20 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117295644 | CMS |
| Ascensia Diabetes Care Us Inc. | $15.48 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089089592 | CMS |
| Saluda Medical Americas, Inc. | $28.83 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093673072 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.02 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137599136 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.